A detailed history of Cwm, LLC transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 48 shares of OLMA stock, worth $286. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48
Previous 1,095 95.62%
Holding current value
$286
Previous $13,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

SELL
$5.61 - $12.72 $5,873 - $13,317
-1,047 Reduced 95.62%
48 $0
Q3 2024

Oct 08, 2024

BUY
$10.41 - $16.46 $124 - $197
12 Added 1.11%
1,095 $13,000
Q2 2024

Jul 09, 2024

BUY
$8.73 - $13.99 $549 - $881
63 Added 6.18%
1,083 $12,000
Q2 2022

Jul 28, 2022

SELL
$2.04 - $4.61 $236 - $534
-116 Reduced 10.21%
1,020 $4,000
Q1 2022

Apr 21, 2022

BUY
$3.89 - $9.43 $3,641 - $8,826
936 Added 468.0%
1,136 $5,000
Q4 2021

Jan 31, 2022

BUY
$8.75 - $30.71 $1,750 - $6,142
200 New
200 $2,000

Others Institutions Holding OLMA

About Olema Pharmaceuticals, Inc.


  • Ticker OLMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,419,600
  • Market Cap $241M
  • Description
  • Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...
More about OLMA
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.